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1. Introduction
Streptococcus pneumoniae (the pneumococcus) 
is a Gram-positive human pathogen that can 
cause life-threatening invasive diseases such as 
pneumonia, bacteremia and meningitis. How S. 
pneumoniae traverses the endothelial cell layer of 
the blood brain barrier is currently unclear. In this 
study, we address the question how S. pneumoniae 
crosses the blood brain barrier. 
2. Methods
Mice were intravenously infected with S. 
pneumoniae, and were sacrificed at various time 
points after infection to mimic the stages preceding 
meningitis. Bacterial localization and endothelial 
cells were detected on brain tissue cryostat-cut 
slides using immunofluorescence. Subsequently 
the location of various host receptors known to 
play a role in the interaction with S. pneumoniae 
was determined using immunofluorescence.
3. Results
Co-localization of  S. pneumoniae within the 
vessels of  the blood-brain barrier occurred 
at specific anatomical sites within the brain 
over time. Confocal analysis confirmed that 
S. pneumoniae is tightly associated with the 
endothelial cells. Analysis of  the systemic 
and local immune response indicated marked 
differences in the local response of  the brain. 
Analysis of the location of various known host 
cell receptors indicated a heterogenous expression 
of these receptors on endothelial cells in the brain. 
Currently, the consequences of this heterogeneity 
for the interaction with the bacteria are further 
investigated using IF and in vitro assays.
4. Conclusions
S. pneumoniae is attached to both the macro- 
and microvascular endothelium in the mouse 
brain depending on the anatomical site. The 
presence of bacteria in the blood elicits markedly 
different responses in the brain compared to 
the systemic response. Furthermore, there was 
a marked heterogeneity in the expression of 
known host cell receptors for S. pneumoniae in the 
brain. Ultimately, this work will lead to a better 
understanding of how pneumococci interact with 
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ABSTRACT: 
Colonization of the nasopharyngeal tract is a first and necessary step in the infectious process 
and often involves the formation of sessile microbial communities by the human pathogen S. 
pneumoniae. The ability to grow and persist as biofilms is an advantage for many microorganisms 
because biofilm-grown bacteria show a reduced susceptibility to antimicrobial agents and hinder 
the recognition by the immune system. Using pneumococcal strains growing as planktonic cultures 
or as biofilms, we have investigated the recognition of S. pneumoniae by the complement system and 
its interactions with human neutrophils. Deposition of C3b, the key complement component, was 
impaired on S. pneumoniae biofilms. In addition, binding of CRP and the complement component 
C1q to the pneumococcal surface was reduced in biofilm-growing bacteria demonstrating that 
pneumococcal biofilms avoid the activation of  the classical complement pathway. Besides, 
recruitment of factor H, the down-regulator of the alternative pathway by a PspC-mediated 
mechanism was enhanced by S. pneumoniae growing as biofilms. Furthermore, phagocytosis of 
pneumococcal biofilms was also impaired. The present study confirms that biofilm formation in 
S. pneumoniae is an efficient way for host immune evasion both from the classical and the PspC-
dependent alternative complement pathways.
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1. Introduction
The growth and dispersal of microbes, whether 
pathogenic or environmental, commonly involve the 
production of biofilms, which represent the primary 
mode of pneumococcal growth during colonization, 
recurrent otitis media and the early stages of invasive 
disease [1]. These evidences support the importance 
of studying pneumococcal sessile communities 
to understand key events in the pathogenesis 
development of this important human pathogen.
Biofilm formation is a complex process initiated 
by the attachment of microorganisms to a surface 
or interface that is embedded in an extracellular 
matrix constituted by various polymeric 
substances [2]. The biological and physicochemical 
characteristics of  biofilm structure protect the 
bacterium from environmental adversities and 
confer the microorganism an inherent resistance 
to antimicrobial therapies and the host immune 
response [3]. The complement system represents 
one of the first lines of defense against invading 
pathogens such as S. pneumoniae and plays a 
vital role in both innate and acquired immu-
nity [4]. This unique host defense mechanism is 
activated by three different pathways —known 
as the classical, alternative and lectin pathways—
that converge at the central com-ponent C3. This 
component is involved in es-sential phases of 
the immune response such as recognition and 
clearance of  microorgan-isms, inflammatory 
response and induction of phagocytosis.
XI European Meeting on the Molecular Biology of the Pneumococcus (EuroPneumo 2013)
Madrid, 28–31 May, 2013Madrid, 28–31 May, 2013
XI European Meeting on the Molecular Biology of the Pneumococcus (EuroPneumo 2013)
193192
2. Results
2.1. C3b deposition on S. pneumoniae growing as 
biofilms or planktonic cultures
The deposition of  the complement compo-
nent C3b on the surface of S. pneumoniae was 
investigated by a flow cytometry assay using 
bacteria grown either as biofilms or as planktonic 
cultures. C3b deposition on pneumococcal 
biofilms was markedly impaired in comparison to 
planktonic cultures. 
2.2. Reduced activation of the clas-sical complement 
pathway by pneumococcal biofilms
The classical complement pathway is activated by 
the recognition of antigen-antibody complexes 
on the bacterial surface by the component C1q 
and it is generally considered to be an effector 
of the acquired immune response. In addition, 
recognition of  S. pneumoniae by acute phase 
proteins such as CRP, increases the deposition 
of C1q on the pneumococcal surface activating 
therefore the classical pathway. Binding to 
pneumococcus by CRP and C1q was reduced 
when the bacteria were grown as a biofilm 
demonstrating that biofilms enhance the resistance 
of S. pneumoniae to complement immunity by 
diminishing the classical pathway activation. 
2.3. Recruitment of human complement regulators
Interaction with the major fluid-phase regulators 
of either the classical or alternative complement 
cascades was investigated by flow cytometry. 
Deposition of C4BP, the main down-regulator 
of the classical pathway is not affected by biofilm 
formation. In contrast, recruitment of  the 
downregulator of the alternative pathway, factor 
H, by a PspC mediated mechanism was enhanced 
by S. pneumoniae growing as biofilms. 
2.4. Phagocytosis by neutrophils is impaired in S. 
pneumoniae biofilms
The susceptibility of pneumococcal biofilms to the 
opsonophagocytosis process mediated by human 
neutrophils was markedly impaired in comparison 
to the planktonic culture, demonstrating that 
the sessile growth of S. pneumoniae represents 
an advantage to avoid the recognition and 
phagocytosis proc-ess mediated by human 
neutrophils.
3. Conclusion
Overall, our study indicates that biofilm for-
mation may constitute an advantage in certain 
phases of the pneumococcal pathogenic process 
such as nasopharyngeal colonization or during the 
early steps of microbial attachment for invasion 
by avoiding the host immune system to efficiently 
recognize and destroy S. pneumoniae.
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ABSTRACT: 
Streptococcus pneumoniae binds the fibrinolysis proenzyme plasminogen (PLG). Here, we 
identified the phosphoglycerate kinase (PGK) as PLG binding protein specifically interacting 
with angiostatin, representing the N-terminal kringle domains 1-3. Electron microscopic analysis 
confirmed surface expression of PGK irrespective of capsule expression. PGK binds human and 
murine PLG with high affinity as shown by Surface Plasmon Resonance (SPR) technique. Results 
of peptide array analyses detected two PLG binding sites (BS1 and BS2). In addition to PLG, 
PGK also directly binds the tissue-type plasminogen activator (tPA). These results point to the 
high relevance of plasminogen binding for S. pneumoniae – host interaction. 
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1. Introduction
Pneumococci bind PLG via a subset of surface 
exposed proteins including the glycolytic enzyme 
enolase [1]. PLG is the proenzyme of the major 
fibrinolysis enzyme plasmin. The host-derived 
PLG activators tPA and urokinase-type PLG 
activator (uPA) convert PLG on the surface of 
pneumococci into the protease plasmin. This 
surface-exposed proteolytic activity facilitates 
pneumococcal transmigration through fibrin 
thrombi and extracellular matrices [2]. The 92 
kDa PLG is composed of five homologous kringle 
domains followed by an enzymatic domain. K1-3 
and K1-4, respectively, comprise angiostatin. 
2. Methods and Results
2.1. Surface-detection of PGK
Recombinant PGK was generated in E. coli to 
subsequently produce antigen-specifc antibodies. 
Following immune detection using electron 
microscopic visualization detected PGK on the 
surface of  encapsulated and non-encapsulated 
isolates (Fig.1).
